2020 ASCO Virtual Direct™ Highlights

 

Skin
09:23

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Melanoma: Dabrafenib + Trametinib in Patients With Resected Stage III BRAF V600-Mutant Melanoma - Is There a Long-Term Survival Benefit?

FEATURING Omar Rashid
  • 54 views
  • September 13, 2020
12:26

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Metastatic Mucosal Melanoma: How Promising Is Toripalimab + Axitinib?

FEATURING Omar Rashid
  • 33 views
  • September 16, 2020
07:40

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on High-Risk Stage III Melanoma: Pembro vs. Placebo - What Is the Incidence of irAEs?

FEATURING Omar Rashid
  • 111 views
  • September 10, 2020